Analyst Rating Update on Stryker Corporation (SYK)

Stryker Corporation (NYSE:SYK) : 14 brokerage houses believe that Stryker Corporation (NYSE:SYK) is a Strong Buy at current levels. 2 Analyst considers the fundamentals to be worthy of a Buy recommendation. 6 analysts believe that the current prices are in a balance with the stocks fundamentals, hence they propose Hold on Stryker Corporation (NYSE:SYK). Zacks Investment Research suggests a Hold with a rank of 3. 2 others believe that the stock has run up ahead of its fundamentals and advise a Strong Sell on the stock.The median of all the 24 Wall Street Analysts endorse the stock as a Buy with a rating of 1.9.

Stryker Corporation (NYSE:SYK) : The highest level Stryker Corporation (NYSE:SYK) is projected to reach is $134 for the short term and the lowest estimate is at $88. The consolidated price target from 18 rating analysts who initiate coverage on the stock is $117.72 and the possibility the share price can swing is $10.07.

For the current week, the company shares have a recommendation consensus of Buy. Also, Guggenheim Securities initiates coverage on Stryker Corporation (NYSE:SYK) The shares have been rated Buy. The rating by the firm was issued on June 9, 2016.

Stryker Corporation (NYSE:SYK): stock turned positive on Tuesday. Though the stock opened at $115.25, the bulls momentum made the stock top out at $116.17 level for the day. The stock recorded a low of $114.79 and closed the trading day at $115.96, in the green by 1.36%. The total traded volume for the day was 1,637,386. The stock had closed at $114.4 in the previous days trading.

In an insider trading activity, Stryker Ronda E, director of Stryker Corp, unloaded 12,000 shares at an average price of $117.25 on June 22, 2016. The total amount of the transaction was worth $1,407,000, according to the disclosed information with the Securities and Exchange Commission in a Form 4 filing.

Stryker Corporation is a medical technology company. The Company offers a range of products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine, which help improve patient and hospital outcomes.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.